Catalent’s SMARTag® Technology: Enabling Precision Design Solutions for Best-In-Class ADCs
- Presenting new data highlighting the improved efficacy and tolerability of SMARTag® ADCs as compared to marketed ADCs against the same target
- Exploring platform features including site-conjugation with optimized payload placement on the antibody
- Showcasing linker-payload solutions to meet your program needs including options with bystander activity, microtubule inhibitors and topo inhibitor mechanisms of action